MedTrace Logo

Non-invasive Mapping Using Ultra-high Frequency Electrocardiography

NCT04537455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-23

No results posted yet for this study

Summary

Cardiac electrical mapping is an important tool that allows doctors to study the electrical activity of the heart in detail. Electrical mapping systems used in clinical practice are time consuming, invasive and very costly. Ultra-high frequency electrocardiography is a novel non-invasive cardiac mapping system. Ultra-high frequency electrocardiography (UHF-ECG) can be performed in 10-15 minutes without any risk or discomfort to patients.

The aim of this study is to refine this mapping system, verify it against invasive mapping and develop software to bring this novel system into routine clinical use including predicting which patients will respond to cardiac resynchronisation therapy.

Conditions

  • Left Bundle-Branch Block
  • Right Bundle-Branch Block
  • Non-Specific Intraventricular Conduction Defect

Interventions

DIAGNOSTIC_TEST

Ultra-high frequency electrocardiography

Patients will have an ultra-high frequency electrocardiography performed.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Zachary Whinnett · Imperial College London

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2023-12-10
Completion
2024-03-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04537455 on ClinicalTrials.gov